Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes

Published:2015-07-14 Issue:2 Volume:33 Page:224-230
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Bethel M. A.¹²,Harrison P.³,Sourij H.¹²,Sun Y.⁴,Tucker L.¹²,Kennedy I.¹²,White S.¹²,Hill L.⁵,Oulhaj A.¹²,Coleman R. L.¹,Holman R. R.¹²

Affiliation:

1. Diabetes Trials Unit; University of Oxford; Oxford UK

2. Oxford National Institute for Health Research Biomedical Research Centre; Churchill Hospital; Oxford UK

3. School of Immunity and Infection; University of Birmingham Medical School; Birmingham UK

4. Peking University People's Hospital; Beijing People's Republic of China

5. Department of Haematology; John Radcliffe Hospital; Oxford UK

Funder

British Heart Foundation

University Of Oxford

National Institute for Health Research

Oxford Biomedical Research Centre Programme

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.12828/fullpdf

Reference26 articles.

1. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials;Baigent;Lancet,2009

2. Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?;Price;Nature Clin Pract Cardiovasc Med,2009

3. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14;ETDRS Investigators;J Am Med Assoc,1992

4. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease;Belch;BMJ,2008

5. Platelet hyperactivity in Type 2 diabetes: role of antiplatelet agents;Natarajan;Diabetes Vasc Dis Res,2008

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin in Primary Prevention: Looking for Those Who Enjoy It;Journal of Clinical Medicine;2024-07-16

2. Thromboxane biosynthesis and future events in diabetes: the ASCEND trial;European Heart Journal;2024-02-22

3. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11

4. The Cellular and Protein Arms of Coagulation in Diabetes: Established and Potential Targets for the Reduction of Thrombotic Risk;International Journal of Molecular Sciences;2023-10-18

5. Diabetes type 2: relationships between lysosomal exocytosis of circulating normal-sized platelets and in vitro ɑ-thrombin-evoked platelet responses;Annals of Medicine;2023-03-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3